Hepatitis C: Opioid Epidemic Leads to More Cases
June 12, 2017
Multiple Sclerosis: ‘You don’t die from MS, you die with it’
June 13, 2017
Show all

Multiple Sclerosis Progression Rate Can Be Reduced with Acne Treatment

An acne medication could have a favorably and unintended benefit to multiple sclerosis patients.

A common acne medicine called minocycline can reduce the rate of multiple sclerosis progression in patients who are at early stages of the disease, according to a Phase 3 clinical trial.

The finding was from the MinoCIS trial (NCT00666887) of minocycline, which goes by the brand name Mynocan and other labels. Canadian researchers published the study, “Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis,” in the New England Journal of Medicine.

 “This study highlights the benefits of evaluating existing therapies for other indications,” Ruth Ann Marrie, a neurologist in Calgary, Canada, said in a press release. “Minocycline is an existing acne medication which is safe, and well-tolerated and it is available for immediate clinical use.”

The multicenter MinoCIS trial included 142 participants between the ages of 18 and 60 who displayed the first signs of what was suspected to be MS 180 days before starting treatment. The patients were randomized to receive either 100 mg of oral minocycline twice a day or a placebo.

Read full article: Multiple Sclerosis Progression Rate Can Be Reduced with Acne Treatment

Read Full Article: Multiple Sclerosis Progression Rate Can Be Reduced with Acne Treatment

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.